http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101771698-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-453 |
filingDate | 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101771698-B1 |
titleOfInvention | 5-amino-4-hydroxypentoyl amides |
abstract | An HIV inhibitor of formula (I) Its pharmaceutically acceptable addition salts and solvates; There is provided a pharmaceutical composition comprising said compound as an active ingredient and a process for producing said compound: In this formula, R 1 is halo, C 1-4 alkoxy, trifluoromethoxy; R 2 is represented by the formula (A) Lt; / RTI > R < 3 > Lt; / RTI > R < 4 > Lt; / RTI > n is 0 or 1; A is CH or N; R 5 and R 6 are hydrogen, C 1-4 alkyl, halo; R 7 and R 8 are C 1-4 alkyl or C 1-4 alkoxy C 1-4 alkyl; R 9 is C 1-4 alkyl, cyclopropyl, trifluoromethyl, C 1-4 alkoxy or dimethylamino; R 10 is hydrogen, C 1-4 alkyl, cyclopropyl, trifluoromethyl, C 1-4 alkoxy or dimethylamino. |
priorityDate | 2009-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 377.